CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia

BACKGROUND: Acquired aplastic anemia (AA) is characterized by deficiency or dysfunction of the bone marrow (BM) microenvironment. However, little is known about the impairment of BM-derived mesenchymal stem cells (MSCs) in AA patients. METHODS: We used Illumina HiSeqTM 2000 sequencing, quantitative...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Shihong, Ge, Meili, Zheng, Yizhou, Li, Jianping, Feng, Xiaoming, Feng, Sizhou, Huang, Jinbo, Feng, Ying, Yang, Donglin, Shi, Jun, Chen, Fang, Han, Zhongchao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540520/
https://www.ncbi.nlm.nih.gov/pubmed/28764810
http://dx.doi.org/10.1186/s13287-017-0620-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540520/
https://www.ncbi.nlm.nih.gov/pubmed/28764810
http://dx.doi.org/10.1186/s13287-017-0620-4

Ejemplares similares